WO2007011647A3 - Inhibiteurs de la kinesine mitotique - Google Patents
Inhibiteurs de la kinesine mitotique Download PDFInfo
- Publication number
- WO2007011647A3 WO2007011647A3 PCT/US2006/027217 US2006027217W WO2007011647A3 WO 2007011647 A3 WO2007011647 A3 WO 2007011647A3 US 2006027217 W US2006027217 W US 2006027217W WO 2007011647 A3 WO2007011647 A3 WO 2007011647A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitors
- mitotic kinesin
- kinesin ksp
- ksp
- mitotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
L'invention se rapporte à des composés et à des procédés qui peuvent servir d'inhibiteurs de la kinésine KSP, pour le traitement ou la prévention des maladies prolifératives cellulaires.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69952105P | 2005-07-15 | 2005-07-15 | |
US60/699,521 | 2005-07-15 | ||
US76161306P | 2006-01-24 | 2006-01-24 | |
US60/761,613 | 2006-01-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007011647A2 WO2007011647A2 (fr) | 2007-01-25 |
WO2007011647A3 true WO2007011647A3 (fr) | 2007-05-18 |
Family
ID=37622033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/027217 WO2007011647A2 (fr) | 2005-07-15 | 2006-07-13 | Inhibiteurs de la kinesine mitotique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007011647A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190016680A1 (en) | 2016-01-14 | 2019-01-17 | Beth Israel Deaconess Medical Center, Inc. | Mast-cell modulators and uses thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003079973A2 (fr) * | 2002-03-08 | 2003-10-02 | Merck & Co., Inc. | Inhibiteurs de kinesine mitotique |
WO2006002236A1 (fr) * | 2004-06-18 | 2006-01-05 | Novartis Vaccines And Diagnostics Inc. | Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer |
WO2006031607A2 (fr) * | 2004-09-13 | 2006-03-23 | Merck & Co., Inc. | Methode de traitement du cancer |
WO2006068933A2 (fr) * | 2004-12-21 | 2006-06-29 | Merck & Co., Inc. | Inhibiteurs de la kinesine mitotique |
WO2006098962A1 (fr) * | 2005-03-09 | 2006-09-21 | Schering Corporation | Composes inhibant l'activite de la kinesine ksp |
WO2006098961A2 (fr) * | 2005-03-09 | 2006-09-21 | Schering Corporation | Composes servant a inhiber l'activite de la kinesine ksp |
-
2006
- 2006-07-13 WO PCT/US2006/027217 patent/WO2007011647A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003079973A2 (fr) * | 2002-03-08 | 2003-10-02 | Merck & Co., Inc. | Inhibiteurs de kinesine mitotique |
WO2006002236A1 (fr) * | 2004-06-18 | 2006-01-05 | Novartis Vaccines And Diagnostics Inc. | Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer |
WO2006031607A2 (fr) * | 2004-09-13 | 2006-03-23 | Merck & Co., Inc. | Methode de traitement du cancer |
WO2006068933A2 (fr) * | 2004-12-21 | 2006-06-29 | Merck & Co., Inc. | Inhibiteurs de la kinesine mitotique |
WO2006098962A1 (fr) * | 2005-03-09 | 2006-09-21 | Schering Corporation | Composes inhibant l'activite de la kinesine ksp |
WO2006098961A2 (fr) * | 2005-03-09 | 2006-09-21 | Schering Corporation | Composes servant a inhiber l'activite de la kinesine ksp |
Also Published As
Publication number | Publication date |
---|---|
WO2007011647A2 (fr) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007011760A3 (fr) | Inhibiteurs de la kinesine mitotique | |
WO2007011759A3 (fr) | Inhibiteurs de la kinesine mitotique | |
WO2008011560A3 (fr) | Inhibiteurs de la rho kinase à base de benzothiophène | |
WO2006078287A3 (fr) | Inhibiteurs de pde4b | |
WO2008079988A3 (fr) | Quinazolines destinés à l'inhibition de pdk1 | |
WO2006023651A3 (fr) | Traitement prolonge de la sclerose en plaques | |
WO2005117867A3 (fr) | Heterocycles monocycliques commes inhibiteurs de kinases | |
WO2007025090A3 (fr) | Inhibiteurs de kinase mapk/erk | |
WO2006071960A3 (fr) | Compositions et procedes de traitement de troubles de la proliferation cellulaire | |
WO2005017190A3 (fr) | Inhibiteurs de kinesine mitotique | |
EP1804794A4 (fr) | Composes de spiropiperidine utilises comme inhibiteurs de beta-secretase en vue du traitement de la maladie d'alzheimer | |
WO2008033562A3 (fr) | Composés inhibiteurs de kinases | |
TW200700422A (en) | Compounds for inhibiting ksp kinesin activity | |
WO2006119329A3 (fr) | Compositions et procedes pour traiter des maladies neurodegeneratives | |
WO2006044775A3 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
WO2006068933A3 (fr) | Inhibiteurs de la kinesine mitotique | |
WO2006113432A3 (fr) | Composes, compositions et procedes | |
WO2005018547A3 (fr) | Inhibiteurs de kinesine mitotique | |
WO2006078574A3 (fr) | Inhibiteurs mitotiques de la kinesine | |
TW200700066A (en) | Compounds for inhibiting ksp kinesin activity | |
WO2005117939A3 (fr) | Utilisation de ligands gpcr54 pour le traitement de l'infertilite | |
WO2008149353A3 (fr) | Composés activant la télomérase et leurs procédés d'utilisation | |
WO2007121125A3 (fr) | Composés organiques et leurs utilisations | |
WO2006086358A3 (fr) | Inhibiteurs de kinesines mitotiques | |
WO2006078598A3 (fr) | Inhibiteurs de la kinesine mitotique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06787160 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06787160 Country of ref document: EP Kind code of ref document: A2 |